Evidence map›Paper›PMID 30359362›Full record

ArticlePLoS biology2018

Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription.

Ieisha Pentland, Karen Campos-León, Marius Cotic, Kelli-Jo Davies, C David Wood, Ian J Groves, Megan Burley, Nicholas Coleman, Joanne D Stockton, Boris Noyvert and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. HPV Integration in Head and Neck Cancer: Downstream Splicing Events and Expression Ratios Linked with Poor Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ieisha PentlandInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Karen Campos-LeónInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Marius CoticInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Kelli-Jo DaviesInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
C David WoodSchool of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Ian J GrovesDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Megan BurleyInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Nicholas ColemanDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Joanne D StocktonInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Boris NoyvertInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Andrew D BeggsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Michelle J WestSchool of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Sally RobertsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Joanna L ParishInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-7111-4211
University of Birmingham · GBUniversity of Cambridge · GBUniversity of Sussex · GB

Funding

Cancer Research UK C31641/A23923Medical Research Council MR/M009157/1Medical Research Council MR/M016587/1Medical Research Council MR/N023498/1Wellcome TrustWellcome Trust 102732/Z/13/Z
6 · The paper itself

Abstract

The complex life cycle of oncogenic human papillomavirus (HPV) initiates in undifferentiated basal epithelial keratinocytes where expression of the E6 and E7 oncogenes is restricted. Upon epithelial differentiation, E6/E7 transcription is increased through unknown mechanisms to drive cellular proliferation required to support virus replication. We report that the chromatin-organising CCCTC-binding factor (CTCF) promotes the formation of a chromatin loop in the HPV genome that epigenetically represses viral enhancer activity controlling E6/E7 expression. CTCF-dependent looping is dependent on the expression of the CTCF-associated Yin Yang 1 (YY1) transcription factor and polycomb repressor complex (PRC) recruitment, resulting in trimethylation of histone H3 at lysine 27. We show that viral oncogene up-regulation during cellular differentiation results from YY1 down-regulation, disruption of viral genome looping, and a loss of epigenetic repression of viral enhancer activity. Our data therefore reveal a key role for CTCF-YY1-dependent looping in the HPV life cycle and identify a regulatory mechanism that could be disrupted in HPV carcinogenesis.

Indexed as

CCCTC-Binding FactorCell DifferentiationChromatinDNA-Binding ProteinsDown-RegulationEpigenesis, GeneticHistonesHumansPapillomaviridaePromoter Regions, GeneticRepressor ProteinsTranscriptional ActivationTranscription FactorsVirus ReplicationYY1 Transcription FactorCCCTC-Binding FactorChromatinCTCFL protein, humanCTCF protein, humanDNA-Binding ProteinsHistonesRepressor ProteinsTranscription FactorsYY1 protein, humanYY1 Transcription Factor

Identifiers

PMID30359362
PMCPMC6219814
OpenAlexW2898087090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.